What is Morgan Stanley's price target for SWAV?

Morgan Stanley's latest stated price target for Shockwave Medical Inc. (SWAV) is $335, from its action on Jul 10, 2023.

What is Morgan Stanley's rating on SWAV?

Morgan Stanley rates SWAV Overweight, a bullish rating, as of Jul 10, 2023.

When did Morgan Stanley last change its view on SWAV?

On Jul 10, 2023, Morgan Stanley upgrades to Overweight from Equal-Weight, price target $291 to $335.

Morgan Stanley SWAV price target and rating history

Shockwave Medical Inc. (SWAV) · Health Care

Morgan Stanley rates Shockwave Medical Inc. (SWAV) Overweight with a $335 price target, as of its latest action on Jul 10, 2023. It has published 5 rating actions on SWAV since August 2021, including 1 upgrade and 0 downgrades.

Current rating: Overweight
Price target: $335
Median target, all firms: Too few
Actions on SWAV: 5

Morgan Stanley price target on SWAV

Morgan Stanley price target on SWAV, each point a stated target, August 2021 to July 2023.

Every Morgan Stanley rating on SWAV

Jul 10, 2023
UpgradeMorgan Stanley upgrades to Overweight from Equal-Weight, price target $291 to $335
May 30, 2023
ResumeMorgan Stanley resumes coverage at Equal-Weight, price target $291
Feb 18, 2022
ReiterateMorgan Stanley cuts its price target to $199 from $210, keeps Equal-Weight
Jan 7, 2022
ReiterateMorgan Stanley raises its price target to $210 from $204, keeps Equal-Weight
Aug 10, 2021
ReiterateMorgan Stanley raises its price target to $200 from $152, keeps Equal-Weight

Questions about Morgan Stanley and SWAV

What is Morgan Stanley's price target for SWAV?: Morgan Stanley's latest stated price target for Shockwave Medical Inc. (SWAV) is $335, from its action on Jul 10, 2023.
What is Morgan Stanley's rating on SWAV?: Morgan Stanley rates SWAV Overweight, a bullish rating, as of Jul 10, 2023.
When did Morgan Stanley last change its view on SWAV?: On Jul 10, 2023, Morgan Stanley upgrades to Overweight from Equal-Weight, price target $291 to $335.

More SWAV rating histories

All Morgan Stanley ratings SWAV news and filings Every analyst firm

From rating actions in the Quantisnow feed. A target holds until the firm states a new one; a reiteration with no target keeps the last one. Not investment advice.